SI

SillaJen, Inc.

Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.

215600 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 중구 청계천로 106 3층(수표동, 크리스탈스퀘어), 중구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SillaJen, Inc. is a biotechnology company focused on the research, development, and commercialization of oncolytic immunotherapeutics for cancer treatment. The company engineers oncolytic viruses designed to selectively replicate in and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its main pipeline candidate is Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus that has been investigated for the treatment of various solid tumors. SillaJen is dedicated to developing innovative therapeutic options for patients with difficult-to-treat cancers through its proprietary viral engineering platforms.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SillaJen, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-09 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획변경승인) (진행성 고형암 또는 재발성/불응성 급성 골수성 백혈병 환자를 대상으로 B…
Korean 28.0 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-05 00:00
Regulatory News Service
불성실공시법인지정 (공시변경)
Korean 6.1 KB

Automate Your Workflow. Get a real-time feed of all SillaJen, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SillaJen, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PharmaSGP Holding SE Logo
Develops and markets leading natural OTC drugs for chronic conditions in the European market.
Germany PSG
Pharmena S.A. Logo
Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.
Poland PHR
Bulgaria PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea 005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands PHARM
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel PMCN-M
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France ALPHE
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy PHIL
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy PRL

Talk to a Data Expert

Have a question? We'll get back to you promptly.